Target intelligence / Profile preview

Bone Marrow-Derived Mononuclear Cells (BMMNCs)

Target
BMMNCs
Molecular classification
Cell Population, Hematopoietic Stem and Progenitor Cells, Mesenchymal Stem/Stromal Cells, Endothelial Progenitor Cells, Lymphocytes, Monocytes, Macrophages
01

Overview

Bone marrow-derived mononuclear cells (BMMNCs) are a heterogeneous population of cells isolated from bone marrow, defined by their single, unilobed or round nuclei and the absence of cytoplasmic granules. They include hematopoietic stem and progenitor cells, mesenchymal stem/stromal cells, endothelial progenitor cells, lymphoid lineage cells, monocytes and macrophages, and other progenitor cells. BMMNCs are studied for their regenerative potential, particularly in cardiovascular and ischemic diseases, due to their ability to promote angiogenesis, modulate immune responses, and support tissue repair via paracrine signaling and differentiation. Isolation is typically performed by density gradient centrifugation. While early clinical trials suggested benefits, more recent studies show only marginal improvements compared with controls.

Other names
BM-MNCsBone marrow mononuclear cells
02

Mechanism of action

N/A

03

Biological functions

HematopoiesisAngiogenesisImmune modulationTissue repairParacrine signalingDifferentiation
04

Disease associations

Cardiovascular diseaseIschemic diseasesMyocardial infarctionCritical limb ischemia
05

Safety considerations

Heterogeneity complicates standardizationMixed clinical trial resultsVariable efficacyLong-term effects unknown
06

Biomarkers

CD34+CD117+CD133+CD90+CD105+CD73+

Beyond the preview

Go deeper on Bone Marrow-Derived Mononuclear Cells (BMMNCs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone Marrow-Derived Mononuclear Cells (BMMNCs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call